Study of SPARC1103 in Subject With Spasticity
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2019
Price : $35 *
At a glance
- Drugs Baclofen (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- Sponsors Sun Pharma Advanced Research Company
- 02 Feb 2018 Status changed from active, no longer recruiting to completed.
- 23 May 2017 Planned End Date changed from 1 Jun 2017 to 1 Sep 2017.
- 23 May 2017 Status changed from recruiting to active, no longer recruiting.